Related Experiment Video
Updated: Mar 24, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction
Kun Gao1, Chenji Wang1, Xiaofeng Jin1
1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, 2005 Songhu Road, Shanghai 200433, China.
Abstract:
The oncoprotein MDM2 is an E3 ubiquitin ligase that targets tumor suppressor p53 for ubiquitination and proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. Dysregulation of MDM2-p53 axis was frequently observed in human cancers. Originally, it is proposed that MDM2 degradation was mainly achieved by destructive self-ubiquitination. However, recent study suggests that MDM2 may be targeted for degradation by an external E3 ubiquitin ligase(s) under physiological levels. Here, we identified E3 ubiquitin ligase RNF12 as an MDM2-interacting protein through yeast two hybrid methods. We demonstrated that RNF12 targets MDM2 for ubiquitination and proteasomal-dependent degradation, which is independent of MDM2's self-ubiquitination activity. Accordingly, RNF12 elevates p53 protein level by abrogating MDM2-mediated p53 degradation and ubiquitination. Finally, we showed that RNF12 regulates cell growth suppression and DNA damage-induced apoptosis in a p53-dependent manner. Taken together, we establish RNF12 as a novel positive regulator of p53 pathway and an external E3 ubiquitin ligase for MDM2 destruction. These data shed light on the potential roles of RNF12 in MDM2-p53 axis and tumor suppression.
Insights
RNF12, an E3 ubiquitin ligase, targets MDM2 for degradation, stabilizing the tumor suppressor p53. This finding reveals RNF12 as a novel regulator of the MDM2-p53 pathway, impacting cancer suppression.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The MDM2-p53 pathway is crucial for cell cycle control and tumor suppression.
- MDM2, an E3 ubiquitin ligase, targets p53 for degradation, promoting cancer cell survival.
- Dysregulation of the MDM2-p53 axis is common in human cancers.
Purpose of the Study:
- To identify novel regulators of the MDM2-p53 axis.
- To investigate the role of RNF12 in MDM2 degradation and p53 stabilization.
- To elucidate the function of RNF12 in tumor suppression.
Main Methods:
- Yeast two-hybrid screening to identify MDM2-interacting proteins.
- Ubiquitination assays to assess MDM2 degradation.
- Western blotting to measure protein levels of MDM2 and p53.
- Cellular assays to evaluate cell growth and apoptosis.
Main Results:
- RNF12 was identified as an MDM2-interacting protein.
- RNF12 mediates the ubiquitination and proteasomal degradation of MDM2, independent of MDM2 self-ubiquitination.
- RNF12 enhances p53 protein levels by inhibiting MDM2-mediated p53 degradation.
- RNF12 promotes p53-dependent cell growth suppression and apoptosis.
Conclusions:
- RNF12 acts as an external E3 ubiquitin ligase targeting MDM2 for destruction.
- RNF12 functions as a positive regulator of the p53 pathway.
- RNF12 has potential roles in tumor suppression via the MDM2-p53 axis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Inhibition of Cdk Activity

